NuLife Ventures Premier Blog Talk Radio show with our first guest, Mr. Tom Muehlbauer, the CEO of AVACEN MEDICAL, our flagship product manufacturer as he dives into discussing the far-reaching significance of the letter below.

For more information on AVACEN visit: www.NuLifeVentures.com

This Video & recorded calls are for educational purposes only. And are only for the use of NuLife Ventures Independent Brand Partners.

--

03/07/2020

Dear NLV Independent Business Partners,

AVACEN has been given the opportunity to present the AVACEN Treatment Method and its potential ability to prevent or treat the Coronavirus (COVID-19) to the US Department of Health and Human Services (HHS) this Friday, March 20th.

As such I have been asked to put together a one-page presentation. I have been asked to supplement my presentation with testimonials of how the AVACEN Device has helped with the issues below.

These testimonials will not be published without your prior permission.

A special email address (COVID@avacen.com) has been set up for those who are willing to share their experiences as they relate to:

Improvement in your immune system.
Improvement in respiratory issues such as COPD.
Avoidance in contracting the Coronavirus after being directly exposed to COVID-19 by those who are of higher risk (older adults and people who have severe underlying chronic medical conditions like heart or lung disease or diabetes).
Rapid recovery from the Coronavirus.

Thank you!

Best Wishes,
TOM
Thomas G. Muehlbauer, CEO
AVACEN Medical

Premier Blog Talk Radio: Tom M. CEO of AVACEN - Coronavirus & the US Dept. (HSS)

Share

Embed